Powered by

RoosterBio Raises $15 Million in Initial Series B Round Led by Dynamk Capital

Aug 06, 2019 - PR Newswire

PR Newswire

Frederick, MD, Aug. 6, 2019 /PRNewswire-PRWeb/ -- RoosterBio Inc, disrupting the market by radically simplifying human mesenchymal stem/stromal cell (hMSC) biomanufacturing, today announced it has raised in excess of $15 million in an initial Series B financing round led by Dynamk Capital. Existing and new investors exhibited strong investment interest, leading to an oversubscribed round. The Series B final round is expected to close with additional investors by the end of Aug...